Technologies developed at the University of California, Davis, enabled the foundation of 14 startup companies during the fiscal year ending June 30, 2019.
“Research universities like UC Davis are a key source of vital innovation for numerous industries,” said Prasant Mohapatra, vice chancellor for research at UC Davis. “These startups are undertaking the important first steps in developing and refining the commercial potential of their inventions. It’s exciting to see such a wide range of entrepreneurial undertakings based on our campus innovations.”
Image: Robert Fairclough, right, emeritus associate professor in the UC Davis Department of Neurology, and Vu Trinh, a postdoctoral researcher at UC Davis, are co-founders of Sierra Biopharma. The company is developing a therapeutic treatment for the autoimmune neuromuscular disease myasthenia gravis. (UC Davis photo)
